Company intelligence
Ethypharm
Beyond our medicines, lives
About Ethypharm
Ethypharm is a leading mid-size international pharmaceutical company, with strong European roots, that manufactures and provides essential medicines, with a focus on Hospital Injectables, Central Nervous System (severe pain and addiction). Our commitment is to improve patients' lives and make a positive impact on society and the environment. Ethypharm has 1,800 employees dedicated to its various pharmaceutical activities, of which 1400 are in industrial operations. Our six production sites located in France, the UK, Spain, and China have expertise in injectables and complex oral solid forms. With a global presence in 68 countries, the company markets its products directly in Europe and China, and has strategic partnerships in the EMEA, NA, LATAM and APAC markets. Ethypharm works closely with the authorities and healthcare professionals to ensure that its medicines are used appropriately and that patients have access to them. To find out more about Ethypharm, visit http://www.ethypharm.com and follow us on LinkedIn.
Verified activity
Signals from Ethypharm
3 published signals
Presence & Recognition
Ethypharm is hosting its first partnership with the Emc2 conference in Monaco on September 10 and 11, 2026.
Reported by Olivier SCHMITT
Presence & Recognition
Ethypharm supported scientific and knowledge-sharing events in the DROM-COM region and in the metropolitan area.
Reported by Olivier SCHMITT
Presence & Recognition
Ethypharm is hosting a multidisciplinary scientific conference on abdominal and pelvic pain on September 8th, 2026, featuring a keynote by Dr. Agnes Ricard-Hibon, Dr. Hortense Dumontier, Dr. Virginie-Eve Lvovschi, Dr. Jennifer Feras, and Dr. Manon Kaced.
Reported by Olivier SCHMITT